TriVascular, a subsidiary of the TV2 Holding Company, has raised $45 million in a third round of funding, according to a filing with the SEC. Based in Santa Rosa, Calif., TriVascular makes endovascular medical devices for aortic repair.
TriVascular was acquired by Boston Scientific in 2005 and then sold to the TV2 Holding Company in 2008. The company last raised $30.5M in equity in 2009.
The company plans to use its latest round to launch an abdominal stent graft system in Europe, according to peHUB. Pinnacle Ventures led the most recent round of funding, and New Enterprise Associates, Delphi Ventures, MPM Capital and Kearny Venture Partners also participated.